ProQR Therapeutics N.V. Ordinary Shares PRQR
i
Market datapartial · fetched 2026-11-04T04:29:40.762Z
Delta surfaceAlpaca · derived absolute-delta buckets · 2026-11-20
Calculation methodologyOptions historyIV: ThetaData historical Greeks, equal-weight mean of call/put 50-delta IV across the next four listed Friday-cycle expirations, including holiday shifts verified against ThetaData’s market calendar. Missing inputs leave gaps. Skew: equal-weight mean of put minus call IV across those four expirations. IV-implied move history: mean of each expiration’s average call/put IV multiplied by the square root of remaining calendar days divided by 365.25; percentage of spot, not a quoted straddle premium.
History dataPriceAlpaca · sip · 2026-11-03T23:07:08.150516066Z
FundamentalsAlpha Vantage · unavailable
ProQR Therapeutics N.V. Ordinary Shares options
Table
| Delta | Calls | Puts | ||||
|---|---|---|---|---|---|---|
| Pseudo strike | IV | B/E move | Pseudo strike | IV | B/E move | |
| 20Δ | 1.04 | 659.3% | 56.9% | |||
| 25Δ | 1.14 | 590.3% | 49.6% | |||
| 30Δ | 1.24 | 521.2% | 42.4% | |||
| 35Δ | 1.34 | 452.2% | 35.1% | |||
| 40Δ | 1.44 | 383.1% | 27.9% | |||
| 45Δ | 1.54 | 333.1% | 22.5% | |||
| 50Δ | 1.63 | 316.4% | 20.3% | |||
| 55Δ | 4.62 | 756.7% | 293.1% | 1.73 | 299.8% | 18.0% |
| 60Δ | 3.79 | 661.0% | 229.2% | 1.82 | 283.1% | 15.8% |
| 65Δ | 2.96 | 565.2% | 165.3% | 1.92 | 266.5% | 13.6% |
| 70Δ | 2.13 | 469.5% | 101.4% | 2.02 | 249.8% | 11.4% |
| 75Δ | 1.29 | 373.7% | 37.5% | 2.11 | 233.2% | 9.1% |
| 80Δ | 0.90 | 353.2% | 12.9% | 2.21 | 216.5% | 6.9% |
20Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.04
- IV
- 659.3%
- B/E move
- 56.9%
25Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.14
- IV
- 590.3%
- B/E move
- 49.6%
30Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.24
- IV
- 521.2%
- B/E move
- 42.4%
35Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.34
- IV
- 452.2%
- B/E move
- 35.1%
40Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.44
- IV
- 383.1%
- B/E move
- 27.9%
45Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.54
- IV
- 333.1%
- B/E move
- 22.5%
50Δ
- Pseudo strike
- IV
- B/E move
- Pseudo strike
- 1.63
- IV
- 316.4%
- B/E move
- 20.3%
55Δ
- Pseudo strike
- 4.62
- IV
- 756.7%
- B/E move
- 293.1%
- Pseudo strike
- 1.73
- IV
- 299.8%
- B/E move
- 18.0%
60Δ
- Pseudo strike
- 3.79
- IV
- 661.0%
- B/E move
- 229.2%
- Pseudo strike
- 1.82
- IV
- 283.1%
- B/E move
- 15.8%
65Δ
- Pseudo strike
- 2.96
- IV
- 565.2%
- B/E move
- 165.3%
- Pseudo strike
- 1.92
- IV
- 266.5%
- B/E move
- 13.6%
70Δ
- Pseudo strike
- 2.13
- IV
- 469.5%
- B/E move
- 101.4%
- Pseudo strike
- 2.02
- IV
- 249.8%
- B/E move
- 11.4%
75Δ
- Pseudo strike
- 1.29
- IV
- 373.7%
- B/E move
- 37.5%
- Pseudo strike
- 2.11
- IV
- 233.2%
- B/E move
- 9.1%
80Δ
- Pseudo strike
- 0.90
- IV
- 353.2%
- B/E move
- 12.9%
- Pseudo strike
- 2.21
- IV
- 216.5%
- B/E move
- 6.9%
Options history
Table
| Date | IV (%) |
|---|---|
| 216.53% | |
| 219.62% | |
| 216.28% | |
| 215.94% | |
| 219.28% | |
| 213.91% | |
| 252.25% | |
| 232.98% | |
| 230.44% |
Biotechnology
PRTA
Prothena Corporation plc, an advanced stage clinical company, is focused on the discovery and development of new therapies for life-threatening diseases in the United States. The…
More →PTCT
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for patients with rare disorders. The company is…
More →PTGX
Description unavailable
More →PVLA
Description unavailable
More →PYPD
Description unavailable
More →PYXS
Description unavailable
More →